Focus (breast MRI)
Citation, DOI, disclosures and article data
At the time the article was created Francis Deng had no recorded disclosures.View Francis Deng's current disclosures
At the time the article was last revised Monica Wong had no recorded disclosures.View Monica Wong's current disclosures
A focus in the context of breast MRI using the BI-RADS lexicon refers to a unique enhancing dot that is too small to characterize further morphologically as a mass or nonmass enhancement. Usually, a focus is smaller than 5 mm.
On this page:
- T1 C-: no corresponding finding; possibly fatty hilum favors a benign process
T1 C+ FS: punctate signal that stands out from the background parenchymal enhancement, usually <5 mm
- delayed images: persistence favors benignity 1, while plateau or washout kinetics are suspicious for malignancy 2, although kinetic data may be spurious due to partial volume averaging 3
- T2: if present, hyperintensity (cyst-like) favors benignity, such as lymph nodes or myxomatous fibroadenomas
The radiologist must decide whether an enhancing area reflects a focus, focal area of nonmass enhancement, mass, or background parenchymal enhancement. For example, if an enhancing finding can be defined by irregular shape, noncircumscribed margins, or internal enhancement characteristics, it should be described as a mass 3. If it does not stand out from other foci, it should be described as background parenchymal enhancement.
A focus may be benign or malignant, with the estimated risk of malignancy differing widely between studies, ranging from 0.6 to 37% 1,2,4-6. At the index study, a focus is commonly assessed as probably benign and short term follow up is recommended (BI-RADS 3). Scattered multiple foci, a focus with long term stability, a decreasing or resolved focus, a focus with 100% persistent delayed kinetics, or a focus with cyst-like features may be considered benign (BI-RADS 2). Conversely, a focus that is new, enlarged, or showing washout kinetics may be viewed as suspicious (BI-RADS 4).
- 1. Eby PR, DeMartini WB, Gutierrez RL, Saini MH, Peacock S, Lehman CD. Characteristics of probably benign breast MRI lesions. (2009) AJR. American journal of roentgenology. 193 (3): 861-7. doi:10.2214/AJR.08.2096 - Pubmed
- 2. Van den Bosch MA, Ikeda DM, Daniel BL. Does size matter? Likelihood of cancer in MRI-detected lesions less than 5 mm. (2007) AJR. American journal of roentgenology. 188 (6): W571. doi:10.2214/AJR.06.1206 - Pubmed
- 3. D’Orsi CJ, Sickles EA, Mendelson EB, Morris EA, et al. ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System. Reston, VA, American College of Radiology; 2013. ISBN:155903016X. Read it at Google Books - Find it at Amazon
- 4. Chikarmane SA, Birdwell RL, Poole PS, Sippo DA, Giess CS. Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management. (2016) Radiology. 280 (3): 707-15. doi:10.1148/radiol.2016151548 - Pubmed
- 5. Clauser P, Cassano E, De Nicolò A, Rotili A, Bonanni B, Bazzocchi M, Zuiani C. Foci on breast magnetic resonance imaging in high-risk women: cancer or not?. (2016) La Radiologia medica. 121 (8): 611-7. doi:10.1007/s11547-016-0644-3 - Pubmed
- 6. Liberman L, Mason G, Morris EA, Dershaw DD. Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion size. (2006) AJR. American journal of roentgenology. 186 (2): 426-30. doi:10.2214/AJR.04.1707 - Pubmed